Aurinia Pharmaceuticals
Yahoo Finance • 7 months ago
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
ROCKVILLE, Md. & EDMONTON, Alberta, April 16, 2024--(BUSINESS WIRE)--NOTE: The new presentation time for Aurinia’s presentation at the 2024 Bloom Burton & Co. Healthcare Investor Conferences is 4:00 to 4:30 PM Eastern Time. This event is p... Full story
Yahoo Finance • 10 months ago
Painful week for retail investors invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) after 5.9% drop, institutions also suffered losses
Key Insights Significant control over Aurinia Pharmaceuticals by retail investors implies that the general public has more power to influence management and governance-related decisions The top 25 shareholders own 32% of the company Insti... Full story
Yahoo Finance • last year
13 Stocks to Buy with Exponential Growth
In this article, we will take a look at the 13 stocks to buy with exponential growth. To see more such companies, go directly to 5 Stocks to Buy with Exponential Growth. Optimism was prevailing in the US stock market on October 11 as inve... Full story
Yahoo Finance • last year
Aurinia Announces 2023 Annual General Meeting Results
EDMONTON, Alberta, May 17, 2023--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) ("Aurinia" or the "Company") today announced voting results for its annual general meeting (the "Meeting") of shareholders held on May 17, 2023.... Full story
Yahoo Finance • 2 years ago
Why Aurinia Pharmaceuticals Stock Is Glowing Green Today
Aurinia Pharmaceuticals (NASDAQ: AUPH), a small-cap commercial-stage drugmaker, is having another strong session today. Following this latest double-digit gain, Aurinia's shares have risen by a staggering 155% so far this year. Today's upt... Full story
Yahoo Finance • 2 years ago
Aurinia Announces PTAB Has Terminated Inter Partes Review
VICTORIA, British Columbia, January 25, 2023--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia) announces that the Patent Trial and Appeal Board (PTAB) of the United States’ Patent and Trademark Office has terminated t... Full story
Yahoo Finance • 2 years ago
Why Shares of Aurinia Pharmaceuticals Soared This Week
Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) were up by 79.6% this week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The biopharmaceutical company, which specializes in treating autoimmune... Full story
Yahoo Finance • 2 years ago
Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference
VICTORIA, British Columbia, January 04, 2023--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, is scheduled to present at the... Full story
Yahoo Finance • 2 years ago
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VICTORIA, British Columbia, December 05, 2022--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune dise... Full story
Yahoo Finance • 2 years ago
Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022
VICTORIA, British Columbia & ROCKVILLE, Md., July 25, 2022--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) ("Aurinia" or the "Company") today announced that it will release financial and operational results for the second qua... Full story
Yahoo Finance • 2 years ago
Why Aurinia Pharmaceuticals Stock Perked Up Today
Shares of the commercial-stage biopharma Aurinia Pharmaceuticals (NASDAQ: AUPH) rose by as much as 13.7% during Friday's trading session. This time around, Japanese drug manufacturer Otsuka Holdings is rumored to be considering a bid, acco... Full story
Yahoo Finance • 2 years ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aurinia Pharmaceuticals Inc., of Class Action Lawsuit and Upcoming Deadline – AUPH
NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”) (NASDAQ: AUPH) and certain of its officers. The class acti... Full story
Yahoo Finance • 2 years ago
AUPH FINAL DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important June 14 Deadline in Securities Class Action – AUPH
NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021 and February 25, 2022, inclusive... Full story
Yahoo Finance • 2 years ago
Aurinia Pharmaceuticals Investors: Class Action Lawsuit Filed on Behalf of Investors; The Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 13, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) ("Aurinia" or the "Compan... Full story
Yahoo Finance • 2 years ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, Stronghold, Aurinia, and Lilium and Encourages Investors to Contact the Firm
NEW YORK, June 08, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Twitter, Inc. (NYSE: TWTR... Full story
Yahoo Finance • 2 years ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stronghold, Aurinia, Lilium, and Li-Cycle and Encourages Investors to Contact the Firm
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stronghold Digital Mining... Full story
Yahoo Finance • 2 years ago
AUPH INVESTOR NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021 and February 25, 2022, inclusive... Full story
Yahoo Finance • 2 years ago
Aurinia Presents Data Demonstrating LUPKYNIS® (voclosporin) is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations
-The post-hoc analysis based on the updated treatment recommendations was presented at the EULAR 2022 European Congress of Rheumatology VICTORIA, British Columbia, June 03, 2022--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)... Full story
Yahoo Finance • 2 years ago
Aurinia Pharmaceuticals Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 02, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) ("Aurinia" or the "Company... Full story
Yahoo Finance • 2 years ago
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AUPH
NEW YORK, May 30, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) between May 7, 2021 and February 25, 2022, inclusive (... Full story
